NCT06214780

Brief Summary

To analyze the effect of heatwaves on interstitial glucose in adult patients with type 1 diabetes mellitus treated with artificial pancreas

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
193

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2024

Shorter than P25 for all trials

Geographic Reach
1 country

9 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 10, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 22, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

January 22, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2024

Completed
Last Updated

August 22, 2024

Status Verified

August 1, 2024

Enrollment Period

3 months

First QC Date

January 10, 2024

Last Update Submit

August 21, 2024

Conditions

Keywords

advanced hybrid closed-loopartificial pancreasheatwaveclimate changeglobal warming

Outcome Measures

Primary Outcomes (1)

  • Change in time in range

    Change in Time in range (TIR) 3.0-10 mmol/L (70-180 mg/d) of interstitial glucose from the heatwaves period to 14 days after its end

    14 days

Secondary Outcomes (10)

  • Adherence to advaced hybrid closed-loop

    14 days

  • Change in Time below range 1 (TBR1)

    14 days

  • Change in Time below range 2 (TBR2)

    14 days

  • Change in Time above range 1 (TAR1)

    14 days

  • Change in Time above range 2 (TAR2)

    14 days

  • +5 more secondary outcomes

Study Arms (1)

Type 1 diabetes patients

Adult patients treated with advanced hybrid closed-loop in Castilla-La Mancha during summer 2023.

Device: advanced hybrid closed-loop

Interventions

An advanced hybrid closed-loop system is a type of insulin delivery system that uses an algorithm to automatically adjust insulin delivery based on glucose levels. It combines an insulin pump with a continuous glucose monitor (CGM) and uses a closed-loop algorithm to adjust insulin doses based on real-time glucose readings. The "hybrid" aspect refers to the fact that the system still requires some user input, such as entering meal information, but the algorithm takes over the majority of insulin dosing decisions.

Type 1 diabetes patients

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult type 1 diabetes patients using AHCL during and after heatwaves in Castilla-La Mancha (Spain).

You may qualify if:

  • Type 1 diabetes
  • Older than 18 years old
  • Using advanced hybrid closed-loop systems (AHCL)
  • Paired active AHCL data from the heatwave periods and two consecutive weeks

You may not qualify if:

  • Younger than 18 years old
  • Not using AHCL
  • Not having active paired AHCL data from the analyzed periods

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

La Mancha-Centro Hospital

Alcázar de San Juan, Ciudad Real, 13600, Spain

Location

Santa Barbara Hospital

Puertollano, Ciudad Real, 13500, Spain

Location

Valdepeñas General Hospital

Valdepeñas, Ciudad Real, 13300, Spain

Location

Virgen del Prado Hospital

Talavera de la Reina, Toledo, 45600, Spain

Location

Albacete University Hospital

Albacete, 02006, Spain

Location

Ciudad Real General University Hospital

Ciudad Real, 13005, Spain

Location

Virgen de la Luz University Hospital

Cuenca, 16002, Spain

Location

Guadalajara University Hospital

Guadalajara, 19002, Spain

Location

Toledo University Hospital

Toledo, 45007, Spain

Location

Related Publications (4)

  • Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Norgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care. 2019 Aug;42(8):1593-1603. doi: 10.2337/dci19-0028. Epub 2019 Jun 8.

    PMID: 31177185BACKGROUND
  • Song X, Jiang L, Zhang D, Wang X, Ma Y, Hu Y, Tang J, Li X, Huang W, Meng Y, Shi A, Feng Y, Zhang Y. Impact of short-term exposure to extreme temperatures on diabetes mellitus morbidity and mortality? A systematic review and meta-analysis. Environ Sci Pollut Res Int. 2021 Nov;28(41):58035-58049. doi: 10.1007/s11356-021-14568-0. Epub 2021 Jun 8.

    PMID: 34105073BACKGROUND
  • Moon J. The effect of the heatwave on the morbidity and mortality of diabetes patients; a meta-analysis for the era of the climate crisis. Environ Res. 2021 Apr;195:110762. doi: 10.1016/j.envres.2021.110762. Epub 2021 Jan 27.

    PMID: 33515577BACKGROUND
  • Moreno-Fernandez J, Sastre J, Herranz S, Pines P, Gomez FJ, Quiroga I, Moya AJ, Gonzalvo C, Miralles R, Calderon-Vicente D, Palma M, Gargallo J, Munoz-Rodriguez JR. Effect of the historic Spanish heatwave over glycemic control in adult patients with type 1 diabetes. Sci Total Environ. 2023 Sep 1;889:164045. doi: 10.1016/j.scitotenv.2023.164045. Epub 2023 May 17.

    PMID: 37201805BACKGROUND

Related Links

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 10, 2024

First Posted

January 22, 2024

Study Start

January 22, 2024

Primary Completion

April 30, 2024

Study Completion

May 31, 2024

Last Updated

August 22, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Under other researchers request.

Locations